Division of Hematology Products (DHP)
Director: Ann Farrell, M.D. (Acting)
Deputy Director: Edvardas Kaminskas, M.D. (Acting)
Deputy Director of Safety: Robert Kane, M.D. (Acting)
Team Leader: Ebla Ali Ibrahim, M.S.
Acting Team Leader: Theresa Carioti
The Division of Hematology Products (DHP) regulates Investigational New Drug Applications (INDs), New Drug Applications (NDAs), and Biologic Licensing Applications (BLAs) for small molecule agents and biologics used in hematology.
The hematology products include those products used predominantly as therapeutic agents in malignant hematological and nonmalignant hematological conditions, such as the treatment of anemias, venous thromboembolism, and platelet disorders.
Food and Drug Administration
Center for Drug Evaluation and Research
Division of Hematology Products
5901-B Ammendale Road
Beltsville, MD 20705-1266
Phone: (301) 796-7550
Fax: (301) 796-9845